Mitoxantrone Completed Phase 1 / 2 Trials for Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003003Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
NCT00002912Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia